Barbara J. Desoer
Known title: DirectorCIK: 0001189881
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
US presses China on Citigroup market access in Bangkok talks. The U.S. government has raised concerns about Citigroup's market access in China during bilateral talks in Bangkok. This diplomatic development highlights the ongoing regulatory and geopolitical risks associated with the bank's international operations. While Citi also initiated coverage on other companies like Mobileye, the trade discussions are the primary factor affecting the stock's broader outlook.
Transaction History
| DVA | ▲ Buy | Grant | 278 | $0 | 8/15/2026 | View on chart |
| DVA | ▲ Buy | Grant | 250 | $0 | 5/15/2026 | View on chart |
| DVA | ▲ Buy | Grant | 332 | $0 | 3/15/2026 | View on chart |
| DVA | ▲ Buy | Grant | 411 | $0 | 11/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 369 | $0 | 8/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 348 | $0 | 5/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 349 | $0 | 3/15/2025 | View on chart |
| C | ▲ Buy | Grant | 529 | $0 | 1/2/2025 | View on chart |
| DVA | ▲ Buy | Grant | 312 | $0 | 11/15/2024 | View on chart |
| DVA | ▲ Buy | Grant | 333 | $0 | 8/15/2024 | View on chart |
| DVA | ▲ Buy | Grant | 363 | $0 | 5/15/2024 | View on chart |
| DVA | ▼ Sell | Open Market | 5,030 | $698K | 5/10/2024 | View on chart |
| DVA | ▲ Buy | Grant | 366 | $0 | 3/15/2024 | View on chart |
| C | ▲ Buy | Grant | 2,923 | $0 | 1/2/2024 | View on chart |
| DVA | ▲ Buy | Grant | 529 | $0 | 11/15/2023 | View on chart |
| DVA | ▲ Buy | Grant | 475 | $0 | 8/15/2023 | View on chart |
| DVA | ▲ Buy | Grant | 516 | $0 | 5/15/2023 | View on chart |
| DVA | ▲ Buy | Option Exercise | 7,165 | $475K | 5/10/2023 | View on chart |
| DVA | ▼ Sell | Other | 4,716 | $475K | 5/10/2023 | View on chart |
| DVA | ▼ Sell | Open Market | 2,449 | $249K | 5/10/2023 | View on chart |
| DVA | ▲ Buy | Grant | 658 | $0 | 3/15/2023 | View on chart |
| C | ▼ Sell | Tax Withholding | 4,401 | $217K | 1/20/2023 | View on chart |
| C | ▲ Buy | Grant | 3,353 | $0 | 1/3/2023 | View on chart |
| DVA | ▲ Buy | Grant | 677 | $0 | 11/15/2022 | View on chart |
| DVA | ▲ Buy | Grant | 514 | $0 | 8/15/2022 | View on chart |
| DVA | ▼ Sell | Open Market | 2,320 | $226K | 6/3/2022 | View on chart |
| DVA | ▲ Buy | Option Exercise | 7,178 | $475K | 5/31/2022 | View on chart |
| DVA | ▼ Sell | Other | 4,858 | $475K | 5/31/2022 | View on chart |
| DVA | ▲ Buy | Grant | 475 | $0 | 5/15/2022 | View on chart |
| DVA | ▲ Buy | Grant | 429 | $0 | 3/15/2022 | View on chart |
| C | ▲ Buy | Grant | 2,255 | $0 | 2/10/2022 | View on chart |
| C | ▼ Sell | Tax Withholding | 7,670 | $493K | 1/20/2022 | View on chart |
| DVA | ▲ Buy | Grant | 446 | $0 | 11/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
DaVita (DVA) Discussed as Potentially Undervalued Cash Producer
Recent articles highlight DaVita as a cash-producing stock that may be undervalued relative to its earnings power. The company has outperformed the broader market recently, with one analysis noting a 58% gain. While the stock is trading near its 52-week low, analysts maintain a higher average price target, suggesting a gap between current price and long-term expectations.
DaVita (DVA) Discussed as Potentially Undervalued Cash Producer. Recent articles highlight DaVita as a cash-producing stock that may be undervalued relative to its earnings power. The company has outperformed the broader market recently, with one analysis noting a 58% gain. While the stock is trading near its 52-week low, analysts maintain a higher average price target, suggesting a gap between current price and long-term expectations.